4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-042495
Co-Chief Executive Officer gave up 541 shares (to pay taxes)
- Co-Chief Executive Officer acquired 1,562 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WEST MICHAEL D Co-Chief Executive Officer | 2018-07-10 | Option exercise | +1,562 | 887,299 | D: show line 1 in the form | ||
| WEST MICHAEL D Co-Chief Executive Officer | 2018-07-10 | Shares withheld for taxes | −541 | $2.20 | $1,190 | 886,758 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WEST MICHAEL D Co-Chief Executive Officer | 2018-07-10 | Option exercise · Restricted Stock Units | −1,562 | 10,938 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…